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Anaerobes and laboratory automation: Like oil and water?
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A B S T R A C T
Diagnostic laboratories are urged to take advantage of novel technological advancements to provide standard-
ized and high-throughput information for clinicians; however, total laboratory automation (TLA) has only
recently been introduced in clinical microbiology in the last 10–12 years. The introduction of total laboratory
automation comes with certain advantages and drawbacks that need to be assessed before the introduction of
such systems in the diagnostic workflow that includes the detection of anaerobic bacteria. For several reasons,
there is yet to be a manufacturer to fully address the issue of anaerobes in the setting of laboratory automation;
the aim of the present paper is to address some of the issues associated with anaerobes in lab automation.
© 2019.
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Due to the increasing costs and continuous demand for efficacy
improvement by governments and relevant stakeholders worldwide,
healthcare institutions are urged to remain competitive and to take
advantage of novel technological advancements. Diagnostic labora-
tories, having a pivotal role in patient care and outcomes, are fac-
ing the demand of effective and high-quality services for the low-
est possible price [1]. The process of automation in medical laborato-
ries has been a steadily increasing trend, including both research and
diagnostic laboratories, such as clinical chemistry, hematology and
molecular biology; however, it has only been recently introduced in
clinical microbiology in the last 10–12 years [2]. Although several
automated inoculators have been introduced to the market, currently
only two manufacturers (Copan and BD Kiestra) offer instrumenta-
tion and services for total laboratory automation (TLA) [3]. The po-
tential advantages of laboratory automation include: savings in per-
sonnel costs, a pronounced increase in productivity and reproducibil-
ity, connection with the laboratory information system (LIS), ma-
trix-assisted laser desorption/ionization time-of-flight mass spectrom-
etry (MALDI-TOF) or antimicrobial susceptibility testing (AST) in-
struments, additional safety for the labor force (both from pathogens
and ergonomic
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injuries; i.e. due to repeated motion, awkward and sustained poses),
the possibility to introduce telemicrobiology services (if the demand
arises), the cost of consumables is relatively constant; therefore, they
can be planned in advance (i.e. in an institutional budget), and it may
also result in significant cost reduction, after the return on investment
(ROI) time has elapsed (which is characteristic to each individual set-
ting) [1–3]. However, there are also drawbacks that must be consid-
ered: the initial costs of the instrumentation and the following main-
tenance costs are very high, coupled by the general expectation of in-
creased production by hospital management, which is usually not fea-
sible in the initial period of introduction; backup methods must be
available in case of a system malfunction and there has to be signif-
icant adaptation in the sample processing workflow and training of
the staff in the laboratory. If the latter is not achieved (logistical is-
sues with sample transport and processing, inadequate training or re-
sistance from the staff, inappropriate or no adjustments in the work-
ing hours of the institution etc.), the turnaround time (TAT) for results
may actually become longer, compared to the conventional laboratory
workflow. In addition, several sample types (tissue samples, aspirates)
and pathogens (strict anaerobes, fungi) have remained on the periph-
ery, when it comes to TLA [1–3].
Until recently, the cultivation and identification of strict anaerobic
bacteria has mostly been a neglected topic of interest in most clini-
cal microbiology laboratories, due to the laborious nature of the iso-
lation, species-level identification and predictable resistance patterns
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tions in almost all anatomical sites (and due to the surge of inter-
est regarding their roles in the human microbiome), nowadays more
laboratories invest resources in the correct identification (aided by
MALDI-TOF MS or 16S rRNA gene sequencing) and susceptibility
testing of these pathogens [5,6]. Despite the promising developments
in rapid ID/AST technologies and surge in interest regarding these mi-
croorganisms, there is yet to be a manufacturer to fully address the
issue of anaerobes in the setting of laboratory automation. The fea-
tures of anaerobic bacteriology in the clinical setting makes its integra-
tion in the TLA workflow difficult, which is unfortunate, because the
added standardization and reproducibility in their inoculation, identifi-
cation and AST would be greatly appreciated. In fact, there are reports
on the rapid (4–8h) identification of anaerobes from blood cultures
(allowing for the supply of information in a clinically relevant time
frame) and on the detection of various resistance mechanisms/typing
using MALDI-TOF MS technology [7,8]. These novel modalities in
the clinical microbiology laboratories could complement automation
at the point of reading the culture, and in the following steps, such as
AST or typing.
Thus far, the cultivation of anaerobes has remained external to
lab automation, as the main problem is that incubators cannot pro-
vide an anaerobic atmosphere at the moment. Nevertheless, there is
an option of incubating the plates in appropriate external anaerobic
systems/incubators, but this breaks the continuity providing anaero-
bic atmosphere. After that, these plates may be inserted into the plate
imaging/screening system for image analysis and subsequent picking
of colonies for further processing [3]. In automated systems, plates
are primarily analyzed based on the pictures of the plates available
in the user interface, with the option of “calling out” the plates for
organoleptic evaluation. Anaerobic pathogens have a characteristic
odor, which is extremely useful in determining their presence dur-
ing presumptive identification. Unfortunately, without calling out the
plates, there is no way to ascertain the smell of the colonies. Never-
theless, the plates spend a significant amount of time in atmospheric
oxygen during their way through the different workstations of the sys-
tem (especially if this process is repeated several times), which may
be detrimental to some bacteria that are particularly sensitive to oxy-
gen (e.g., Fusobacterium spp., Solobacterium moorei) [9]. An oxy-
gen-shock of 15–30min may be lethal to the strict anaerobes (those
not possessing any superoxide-dismutase or catalase enzymes), both
directly after the inoculation of plates and after the colonies are al-
ready present on the culture media.
An advantage of automated systems is the consistent way of streak-
ing, which additionally allows for consistent, comparable and reliable
results (i.e. isolated colonies), even from samples with low colony
counts. However, there is also the concern regarding the picking of
colonies for analysis using the electronic interface. In addition, some
samples cannot be incorporated in the preanalytical automated sys-
tems aiming to provide a liquid sample (which is the pre-requisite
for plating automation); therefore, these samples have to be processed
in partially automated system, additionally complicating laboratory
logistics [3]. These samples are usually considered “precious” (e.g.,
surgical samples, tissue samples acquired by biopsy, abscesses, as-
pirates), and coincidentally, the clinical relevance of the isolation of
anaerobes in these sample types is high.
Anaerobes predominantly occur in mixed infections and the size
of their colonies are much smaller, compared to facultative anaer-
obes; although in some cases, the color of their colonies may aid vi-
sual interpretation (depending on the culture media). Adequate im-
age quality and careful selection are needed to process the pathogens
of importance further. However, the users may actually lose pinpoint
colonies during the process of imaging, where a pixel problem could
mask colonies and mislead the microbiologists. The same issue may
plague the processing of polymicrobial samples: without the adequate
image quality, the separation of (which frequently grow on top of each
other) is close to impossible (or depends on the expertise/experience
of the laboratory assistants). As some anaerobes produce fluorescence
under ultraviolet light (which is a useful feature during presumptive
identification), a UV-panel may aid colony picking in mixed (aero-
bic-anaerobic) cultures and for small colonies [10].
There are a number of potential ways to aid the inclusion of anaer-
obes in an automated system. The introduction of a dedicated anaero-
bic incubator system (chamber) in the workflow of the existing auto-
mated systems could be a possible solution. This chamber should be
as close as possible to the site of medium inoculation, to prevent the
damaging effects of oxygen against these microorganisms. If manage-
able, the development of a “fast lane” (which would have the ability to
rapidly transfer anaerobic plates only in the shortest possible time) or
a sealed, anaerobic pathway on the carousel (from the inoculation site
to the chamber) would ensure the viability of these pathogens. Anaer-
obic culture media could be differentiated by the machine with the use
of barcoding thus, these plates would automatically be transferred sep-
arately from aerobic plates on the carousel. Another welcome addi-
tion would be the installation of cameras inside the anaerobic cham-
ber, to allow for the inspection of individual plates without the need
to remove them from anaerobic environment. This way, only those
plates would need to be exposed to oxygen, where further process-
ing (colony picking for MALDI-TOF or AST) is indicated. The im-
provements in optical technologies and image processing (resulting in
sharper images) Although this technology is still in the experimental
phases of development, so-called “electronic noses” (or e-sensing de-
vices) may be utilized in these systems for the detection of short-chain
fatty acids produced by these microorganisms, obviating the need to
actually smell the plates.
In summary, laboratory automation gives the opportunity to clini-
cal microbiology laboratories to take advantage of current technolog-
ical advancements to provide standardized and high-throughput infor-
mation for clinicians and by proxy, care for the patients. Strict anaer-
obes are a group of pathogens, where there are still concerns and is-
sues not addressed by companies, mainly due to their biological prop-
erties; however this may be influenced by the still existing disinter-
est in their cultivation in some laboratories; therefore, maybe the need
is just not present yet. In addition, the differences in sample volumes
(e.g., urine, respiratory and fecal samples arrive to clinical microbiol-
ogy in much larger numbers and they are already in liquid form, ready
for processing) may also have an influence, if observed from a finan-
cial perspective [1–3,11,12]. With the description of anaerobes in vari-
ous infectious processes in increasing amount, developers should soon
reconsider this area as a potential field of future development.
Abbreviation
AST: antimicrobial susceptibility testing; ID: identification; LIS:
laboratory information system; MALDI-TOF MS: matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry; ROI: re-
turn on investment; TAT: turnaround time; TLA: total laboratory au-
tomation; UV: ultraviolet.
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